Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 May;275(5):1239-1247.
doi: 10.1007/s00405-018-4920-9. Epub 2018 Mar 8.

Improved overall survival in head and neck cancer patients after specific therapy of distant metastases

Affiliations

Improved overall survival in head and neck cancer patients after specific therapy of distant metastases

Dominik Schulz et al. Eur Arch Otorhinolaryngol. 2018 May.

Abstract

Purpose: While metastases directed therapy for oligometastatic disease is recommended in different cancer entities, the treatment of solitary metastases in head and neck squamous cell carcinoma (HNSCC) patients is not clearly defined.

Methods: A retrospective analysis was performed on data from 143 HNSCC patients treated between 2001 and 2016 in a tertiary university hospital. Clinical factors and outcome were measured using the median survival of patients receiving metastases specific therapy in comparison with matched control patients.

Results: In 37 patients, distant metastases were treated specifically with either surgery and/or stereotactic ablative radiotherapy and had with 23.97 months a more than three times higher median survival than 10 untreated matched controls with potentially treatable distant metastases (7.07 months).

Conclusions: Our retrospective analysis demonstrates a significant survival benefit for HNSCC patients who received a specific therapy regarding distant metastasis irrespective of localization as compared to a matched control cohort.

Keywords: Distant metastases; HNSCC; Overall survival; Radiotherapy; Specific treatment.

PubMed Disclaimer

References

    1. Crit Rev Oncol Hematol. 2014 Jul;91(1):47-63 - PubMed
    1. Urology. 2003 Feb;61(2):314-9 - PubMed
    1. Nat Rev Clin Oncol. 2011 Jun;8(6):378-82 - PubMed
    1. CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108 - PubMed
    1. Dis Colon Rectum. 2010 Jul;53(7):1080-92 - PubMed

MeSH terms

LinkOut - more resources